SCHEMBL21653010

SCHEMBL21653010

O=C(Nc1cc(F)c(=O)n(CC(F)F)c1)c1cc(F)c(F)s1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.32
▸ KMT2A Q03164 4/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CTDSP1 Q9GZU7 1/20 0.32
▸ NPC1 O15118 4/20 0.32
▸ MAPT P10636 4/20 0.32
▸ RAB9A P51151 4/20 0.32
▸ LMNA P02545 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ MET P08581 1/20 0.32
▸ AXL P30530 1/20 0.32
▸ POLB P06746 2/20 0.31
▸ PPARG P37231 1/20 0.31
▸ NCOA2 Q15596 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ PDE7A Q13946 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21653021 0.89 MAPT (0.34) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21652863 0.88 MAPT (0.32) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21652918 0.85 GSK3B (0.36) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21653248 0.83 MET (0.34) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21652923 0.82 FSCN1 (0.33) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21652926 0.81 RAF1 (0.37) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21633837 0.81 MAPT (0.39) MEN1KMT2AMAPTHTTMET
SCHEMBL21653062 0.80 MAPT (0.32) MEN1KMT2ATDP1CYP1A2CTDSP1
SCHEMBL21653146 0.80 MET (0.33) KMT2AMAPTHTTSMN1; SMN2MET
SCHEMBL21653057 0.80 MAPT (0.37) MEN1KMT2ATDP1CYP1A2CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023657-A1 PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS Epizyme, Inc. (US) 2020-01-30 — — WO disclosed
Send feedback